Document is current
Any future updates will be listed below
-
Authors
Maas-Bauer, Kristina https://orcid.org/0000-0003-1788-2807
Meyer, Thomas https://orcid.org/0009-0005-1868-2083
Yücel, Mehtap
Garofalaki, Maria
Koßmann, Stefanie
Biavasco, Francesca
Lysandrou, Memnon
Waterhouse, Miguel https://orcid.org/0000-0001-7382-4551
Feuchtinger, Tobias
Pfeifer, Dietmar
Ingelfinger, Florian
Wertheimer, Tobias
Duyster, Justus https://orcid.org/0000-0001-7325-7753
Ahn, Jae Sook https://orcid.org/0000-0003-3078-5024
Soiffer, Robert J. https://orcid.org/0000-0002-5810-1192
Finke, Jürgen https://orcid.org/0000-0002-1799-5927
Wäsch, Ralph https://orcid.org/0000-0002-0813-3444
Spyridonidis, Alexandros https://orcid.org/0000-0003-3097-2532
Kim, Dennis Dong Hwan https://orcid.org/0009-0003-9228-1793
Wehr, Claudia https://orcid.org/0000-0002-5037-6175
Zeiser, Robert https://orcid.org/0000-0001-6565-3393
-
Funding
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung (2021_EKEA.131)
Bundesministerium für Bildung, Wissenschaft, Forschung und Technologie (01EO210)
Deutsche Forschungsgemeinschaft (441891347, P22)
Deutsche Forschungsgemeinschaft (441891347, P22)
Deutsche Forschungsgemeinschaft (441891347, P23)
Deutsche Forschungsgemeinschaft (441891347, P24)
Deutsche Forschungsgemeinschaft (441891347, P01)
Deutsche Forschungsgemeinschaft (ZE 872/4-2)
Deutsche Krebshilfe (Max-Eder-Fellowship)
Deutsche Krebshilfe (70113473)
- License Information
-
More Information
Article History
Received: 19 September 2025
Revised: 21 January 2026
Accepted: 25 February 2026
First Online: 3 April 2026
Competing interests
: KMB received travel support from Sanofi. RZ received honoraria from Incyte, Novartis, Sanofi and Mallinckrodt all outside of the work reported here. RW consulted for and/or received honoraria from Abbvie, Alexion, Amgen, BMS, Johnson & Johnson, Kite/Gilead, Novartis, Pfizer, Sanofi, Takeda and received research funding from Johnson & Johnson and Sanofi all paid to UKF. CW received travel support or honoraria from Takeda, Jazz Pharmaceuticals, mundipharma and Grifols. RJS consulted and/or received honoraria from BMS, Cugene and Merck.
